Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Gossamer Bio, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
DE
D. E. Shaw & Co., Inc.
|
41.0M | 669.27% | +40.6M (+10417.7%) | 2025 | 0.0% | |
|
Shares held by quarter
Peak holding41.0M (Q2'26)
Change over 8 quarters+41.0M
Share of the company669.270%
|
||||||
|
6C
683 Capital Management, LLC
|
39.2M | 640.50% | +34.2M (+684.0%) | 2023 | 0.3% | |
|
Shares held by quarter
Peak holding39.2M (Q2'26)
Change over 8 quarters+33.4M
Share of the company640.500%
|
||||||
28 more super investors behind a free account
See every manager holding Gossamer Bio, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
IR
iShares Trust
|
$1.59M | 4.8M | 79.11% | 0.00% | March 31, 2026 |
|
VT
Vanguard Index Funds
|
$1.14M | 6.9M | 112.92% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Gossamer Bio, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CC
Carmen Chang
5%+ holder
13D · 1.7%
|
4.1M | 66.42% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AB
Ali Behbahani
5%+ holder
13D · 1.7%
|
4.1M | 66.42% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
20 more holders behind a free account
See every insider and 5%+ holder of Gossamer Bio, Inc..
Sign up freeLoading...